Controlling Hyperactive Immunity With Long-lived Lymphocytes
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Recruiting · NCT07473154 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Controlling Hyperactive Immunity With Long-lived Lymphocytes | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, diffuse scleroderma, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic sclerosis | Recruiting | Phase 1 / Phase 2 | 2026-08-21 | NCT07473154 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quell Therapeutics Limited | 3 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guy's & St Thomas NHS Foundation Trust | London | United Kingdom | 1 |
| Hospital Universitario Fundacion Jimenez Diaz | Madrid | Spain | 16 |
| Leeds Teaching Hospitals NHS Trust | Leeds | United Kingdom | 25 |
| Manchester University NHS Foundation Trust | Manchester | United Kingdom | 17 |
| Newcastle Upon Tyne NHS Foundation Trust | Newcastle | United Kingdom | 1 |
| Royal Free London NHS Foundation Trust | London | United Kingdom | 15 |
| University Hospital Düsseldorf | Düsseldorf | Germany | 2 |
| University Hospitals Birmingham NHS Foundation Trust | Birmingham | United Kingdom | 12 |
| University of Oxford - The Kennedy Institute | Oxford | United Kingdom | 1 |
| Universitätsklinikum Erlangen | Erlangen | Germany | 20 |